{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:13:33Z","timestamp":1789827213327,"version":"4.0.1"},"reference-count":7,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annalsthoracicsurgery.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Annals of Thoracic Surgery"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.athoracsur.2018.08.067","type":"journal-article","created":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T02:42:21Z","timestamp":1539398541000},"page":"e273-e274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Complete Tumor Response of Tracheal Squamous Cell Carcinoma After Treatment With Pembrolizumab"],"prefix":"10.1016","volume":"107","author":[{"given":"Bradley","family":"Maller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Kaszuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawee","family":"Tanvetyanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.athoracsur.2018.08.067_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/107327480100800405","article-title":"Endobronchial management of advanced lung cancer","volume":"8","author":"Simoff","year":"2001","journal-title":"Cancer Control"},{"key":"10.1016\/j.athoracsur.2018.08.067_bib2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.21037\/acs.2018.03.04","article-title":"Overview of malignant tracheal tumors","volume":"7","author":"Madariaga","year":"2018","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.athoracsur.2018.08.067_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/lary.24123","article-title":"Management and prognosis of primary tracheal cancer: a national analysis","volume":"124","author":"Nouraei","year":"2014","journal-title":"Laryngoscope"},{"key":"10.1016\/j.athoracsur.2018.08.067_bib4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.amjoto.2017.08.005","article-title":"Survival trends in patients with tracheal carcinoma from 1973 to 2011","volume":"38","author":"Agrawal","year":"2017","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.athoracsur.2018.08.067_bib5","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/annonc\/mdx076","article-title":"Pembrolizumab KEYNOTE-001: an adaptive study leading to accelerated approval for two indications and a companion diagnostic","volume":"28","author":"Kang","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.athoracsur.2018.08.067_bib6","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.athoracsur.2016.08.021","article-title":"Successful treatment of an aggressive tracheal malignancy with immunotherapy","volume":"103","author":"Osho","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2018.08.067_bib7","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N\u00a0Engl J Med"}],"container-title":["The Annals of Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497518314760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497518314760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T04:00:23Z","timestamp":1757736023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003497518314760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0003497518314760"],"URL":"https:\/\/doi.org\/10.1016\/j.athoracsur.2018.08.067","relation":{},"ISSN":["0003-4975"],"issn-type":[{"value":"0003-4975","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complete Tumor Response of Tracheal Squamous Cell Carcinoma After Treatment With Pembrolizumab","name":"articletitle","label":"Article Title"},{"value":"The Annals of Thoracic Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athoracsur.2018.08.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The Society of Thoracic Surgeons Published by Elsevier","name":"copyright","label":"Copyright"}]}}